In early August, Novo Nordisk announced that Wegovy reduces the risk of heart attack, stroke or heart-related death in people with cardiovascular disease and obesity by 20%, a result expected to boost use of the medicine even further
10.3389/fncel.2013.00028 68
Three compounds, 2% NaHCO 3 , 2% Na 2 CO 3 , and 2% NaH 2 PO 4 , were incorporated as an intragranular excipient in AD formulations
Glucagon-like peptide-1 (GLP-1) medications like semaglutide and tirzepatide, with brands such as Ozempic and Mounjaro, designed for diabetes, and Wegovy and Zepbound, designed for weight loss, have been soaring in popularity due to their effectiveness as weight loss aids
How Does Gut Bacteria Affect Weight
doi: 10.1586/14779072.2.2.203 11 LicataGArganoCDi ChiaraTParrinelloGScaglioneR